nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.04	0.0809	CbGbCtD
Pergolide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0376	0.0761	CbGbCtD
Pergolide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0376	0.0761	CbGbCtD
Pergolide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.034	0.0688	CbGbCtD
Pergolide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.034	0.0688	CbGbCtD
Pergolide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0294	0.0594	CbGbCtD
Pergolide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0285	0.0576	CbGbCtD
Pergolide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0258	0.0521	CbGbCtD
Pergolide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0258	0.0521	CbGbCtD
Pergolide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0255	0.0514	CbGbCtD
Pergolide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0239	0.0484	CbGbCtD
Pergolide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0239	0.0484	CbGbCtD
Pergolide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0216	0.0437	CbGbCtD
Pergolide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0216	0.0437	CbGbCtD
Pergolide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0187	0.0378	CbGbCtD
Pergolide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0181	0.0367	CbGbCtD
Pergolide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0331	CbGbCtD
Pergolide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0164	0.0331	CbGbCtD
Pergolide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0157	0.0318	CbGbCtD
Pergolide—DRD1—nerve—acquired immunodeficiency syndrome	0.00352	0.0541	CbGeAlD
Pergolide—DRD2—nerve—acquired immunodeficiency syndrome	0.00208	0.032	CbGeAlD
Pergolide—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00174	0.0268	CbGeAlD
Pergolide—HTR2A—nerve—acquired immunodeficiency syndrome	0.00137	0.0211	CbGeAlD
Pergolide—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00136	0.0208	CbGeAlD
Pergolide—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0188	CbGeAlD
Pergolide—DRD4—brain—acquired immunodeficiency syndrome	0.0012	0.0185	CbGeAlD
Pergolide—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00117	0.018	CbGeAlD
Pergolide—DRD3—nervous system—acquired immunodeficiency syndrome	0.00111	0.017	CbGeAlD
Pergolide—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00107	0.0164	CbGeAlD
Pergolide—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0159	CbGeAlD
Pergolide—DRD5—nervous system—acquired immunodeficiency syndrome	0.00104	0.0159	CbGeAlD
Pergolide—DRD5—central nervous system—acquired immunodeficiency syndrome	0.000998	0.0153	CbGeAlD
Pergolide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000961	0.0148	CbGeAlD
Pergolide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000946	0.0145	CbGeAlD
Pergolide—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000935	0.0144	CbGeAlD
Pergolide—DRD2—retina—acquired immunodeficiency syndrome	0.000862	0.0132	CbGeAlD
Pergolide—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00085	0.0131	CbGeAlD
Pergolide—DRD3—brain—acquired immunodeficiency syndrome	0.000846	0.013	CbGeAlD
Pergolide—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000832	0.0128	CbGeAlD
Pergolide—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000818	0.0126	CbGeAlD
Pergolide—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000801	0.0123	CbGeAlD
Pergolide—DRD5—brain—acquired immunodeficiency syndrome	0.000793	0.0122	CbGeAlD
Pergolide—DRD1—nervous system—acquired immunodeficiency syndrome	0.000792	0.0122	CbGeAlD
Pergolide—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000763	0.0117	CbGeAlD
Pergolide—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000762	0.0117	CbGeAlD
Pergolide—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000748	0.0115	CbGeAlD
Pergolide—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000731	0.0112	CbGeAlD
Pergolide—HTR2B—blood—acquired immunodeficiency syndrome	0.000712	0.0109	CbGeAlD
Pergolide—HTR2B—vagina—acquired immunodeficiency syndrome	0.00066	0.0101	CbGeAlD
Pergolide—ADRA1B—brain—acquired immunodeficiency syndrome	0.00065	0.00998	CbGeAlD
Pergolide—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000642	0.00986	CbGeAlD
Pergolide—ADRA1D—brain—acquired immunodeficiency syndrome	0.000636	0.00976	CbGeAlD
Pergolide—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000625	0.0096	CbGeAlD
Pergolide—HTR2B—lung—acquired immunodeficiency syndrome	0.000624	0.00959	CbGeAlD
Pergolide—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000622	0.00955	CbGeAlD
Pergolide—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000618	0.00949	CbGeAlD
Pergolide—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000616	0.00945	CbGeAlD
Pergolide—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000615	0.00944	CbGeAlD
Pergolide—DRD1—brain—acquired immunodeficiency syndrome	0.000606	0.0093	CbGeAlD
Pergolide—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000598	0.00919	CbGeAlD
Pergolide—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000593	0.0091	CbGeAlD
Pergolide—ADRA1A—blood—acquired immunodeficiency syndrome	0.000588	0.00903	CbGeAlD
Pergolide—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000578	0.00888	CbGeAlD
Pergolide—HTR2A—retina—acquired immunodeficiency syndrome	0.000569	0.00873	CbGeAlD
Pergolide—KCNH2—blood—acquired immunodeficiency syndrome	0.000568	0.00873	CbGeAlD
Pergolide—ADRA2C—blood—acquired immunodeficiency syndrome	0.000561	0.00861	CbGeAlD
Pergolide—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000557	0.00855	CbGeAlD
Pergolide—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.00055	0.00844	CbGeAlD
Pergolide—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000547	0.00841	CbGeAlD
Pergolide—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.00054	0.00829	CbGeAlD
Pergolide—KCNH2—vagina—acquired immunodeficiency syndrome	0.000527	0.00809	CbGeAlD
Pergolide—ADRA2C—vagina—acquired immunodeficiency syndrome	0.00052	0.00798	CbGeAlD
Pergolide—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000518	0.00796	CbGeAlD
Pergolide—DRD2—lung—acquired immunodeficiency syndrome	0.000506	0.00776	CbGeAlD
Pergolide—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000499	0.00766	CbGeAlD
Pergolide—ADRA2C—lung—acquired immunodeficiency syndrome	0.000491	0.00755	CbGeAlD
Pergolide—HTR1B—brain—acquired immunodeficiency syndrome	0.000491	0.00754	CbGeAlD
Pergolide—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000478	0.00733	CbGeAlD
Pergolide—HTR1D—brain—acquired immunodeficiency syndrome	0.000475	0.0073	CbGeAlD
Pergolide—HTR2C—brain—acquired immunodeficiency syndrome	0.000471	0.00722	CbGeAlD
Pergolide—DRD2—nervous system—acquired immunodeficiency syndrome	0.000468	0.00719	CbGeAlD
Pergolide—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000461	0.00708	CbGeAlD
Pergolide—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00046	0.00706	CbGeAlD
Pergolide—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000455	0.00699	CbGeAlD
Pergolide—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000451	0.00692	CbGeAlD
Pergolide—ADRA2A—blood—acquired immunodeficiency syndrome	0.000447	0.00687	CbGeAlD
Pergolide—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000444	0.00682	CbGeAlD
Pergolide—HTR2B—brain—acquired immunodeficiency syndrome	0.000442	0.00679	CbGeAlD
Pergolide—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000438	0.00673	CbGeAlD
Pergolide—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000431	0.00662	CbGeAlD
Pergolide—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000427	0.00656	CbGeAlD
Pergolide—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000415	0.00637	CbGeAlD
Pergolide—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000399	0.00613	CbGeAlD
Pergolide—HTR1A—brain—acquired immunodeficiency syndrome	0.000396	0.00608	CbGeAlD
Pergolide—ADRA2A—lung—acquired immunodeficiency syndrome	0.000392	0.00602	CbGeAlD
Pergolide—HTR2A—blood—acquired immunodeficiency syndrome	0.00038	0.00584	CbGeAlD
Pergolide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00037	0.00568	CbGeAlD
Pergolide—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000366	0.00563	CbGeAlD
Pergolide—ADRA1A—brain—acquired immunodeficiency syndrome	0.000365	0.00561	CbGeAlD
Pergolide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000364	0.00559	CbGeAlD
Pergolide—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000363	0.00558	CbGeAlD
Pergolide—DRD2—brain—acquired immunodeficiency syndrome	0.000358	0.00549	CbGeAlD
Pergolide—HTR2A—vagina—acquired immunodeficiency syndrome	0.000353	0.00541	CbGeAlD
Pergolide—KCNH2—brain—acquired immunodeficiency syndrome	0.000353	0.00541	CbGeAlD
Pergolide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000352	0.00541	CbGeAlD
Pergolide—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00035	0.00537	CbGeAlD
Pergolide—ADRA2C—brain—acquired immunodeficiency syndrome	0.000348	0.00534	CbGeAlD
Pergolide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000347	0.00532	CbGeAlD
Pergolide—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000341	0.00523	CbGeAlD
Pergolide—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000336	0.00516	CbGeAlD
Pergolide—HTR2A—lung—acquired immunodeficiency syndrome	0.000333	0.00512	CbGeAlD
Pergolide—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000309	0.00474	CbGeAlD
Pergolide—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000297	0.00457	CbGeAlD
Pergolide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000286	0.00439	CbGeAlD
Pergolide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000281	0.00432	CbGeAlD
Pergolide—ADRA2A—brain—acquired immunodeficiency syndrome	0.000278	0.00426	CbGeAlD
Pergolide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000275	0.00423	CbGeAlD
Pergolide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000271	0.00416	CbGeAlD
Pergolide—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000268	0.00412	CbGeAlD
Pergolide—HTR2A—brain—acquired immunodeficiency syndrome	0.000236	0.00362	CbGeAlD
Pergolide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000215	0.0033	CbGeAlD
Pergolide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000144	0.000404	CcSEcCtD
Pergolide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000404	CcSEcCtD
Pergolide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000404	CcSEcCtD
Pergolide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000144	0.000403	CcSEcCtD
Pergolide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000402	CcSEcCtD
Pergolide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000143	0.000401	CcSEcCtD
Pergolide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000401	CcSEcCtD
Pergolide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.0004	CcSEcCtD
Pergolide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.0004	CcSEcCtD
Pergolide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.0004	CcSEcCtD
Pergolide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000143	0.0004	CcSEcCtD
Pergolide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000142	0.000399	CcSEcCtD
Pergolide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000399	CcSEcCtD
Pergolide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000398	CcSEcCtD
Pergolide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000398	CcSEcCtD
Pergolide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000398	CcSEcCtD
Pergolide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000397	CcSEcCtD
Pergolide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000397	CcSEcCtD
Pergolide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000397	CcSEcCtD
Pergolide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000397	CcSEcCtD
Pergolide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000396	CcSEcCtD
Pergolide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000396	CcSEcCtD
Pergolide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000395	CcSEcCtD
Pergolide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.000395	CcSEcCtD
Pergolide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000394	CcSEcCtD
Pergolide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000393	CcSEcCtD
Pergolide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000393	CcSEcCtD
Pergolide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000393	CcSEcCtD
Pergolide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000392	CcSEcCtD
Pergolide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000392	CcSEcCtD
Pergolide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000392	CcSEcCtD
Pergolide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000392	CcSEcCtD
Pergolide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000391	CcSEcCtD
Pergolide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000391	CcSEcCtD
Pergolide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000391	CcSEcCtD
Pergolide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000389	CcSEcCtD
Pergolide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000138	0.000387	CcSEcCtD
Pergolide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000387	CcSEcCtD
Pergolide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000387	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000387	CcSEcCtD
Pergolide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000387	CcSEcCtD
Pergolide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000384	CcSEcCtD
Pergolide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000384	CcSEcCtD
Pergolide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000384	CcSEcCtD
Pergolide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000384	CcSEcCtD
Pergolide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000383	CcSEcCtD
Pergolide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000383	CcSEcCtD
Pergolide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.000382	CcSEcCtD
Pergolide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.000382	CcSEcCtD
Pergolide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000382	CcSEcCtD
Pergolide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000381	CcSEcCtD
Pergolide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000381	CcSEcCtD
Pergolide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000136	0.00038	CcSEcCtD
Pergolide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000136	0.00038	CcSEcCtD
Pergolide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.00038	CcSEcCtD
Pergolide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.00038	CcSEcCtD
Pergolide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000379	CcSEcCtD
Pergolide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000379	CcSEcCtD
Pergolide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000379	CcSEcCtD
Pergolide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000378	CcSEcCtD
Pergolide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000377	CcSEcCtD
Pergolide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000377	CcSEcCtD
Pergolide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000377	CcSEcCtD
Pergolide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000377	CcSEcCtD
Pergolide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000376	CcSEcCtD
Pergolide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000376	CcSEcCtD
Pergolide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000375	CcSEcCtD
Pergolide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000374	CcSEcCtD
Pergolide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000373	CcSEcCtD
Pergolide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000371	CcSEcCtD
Pergolide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000132	0.00037	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00037	CcSEcCtD
Pergolide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00037	CcSEcCtD
Pergolide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000369	CcSEcCtD
Pergolide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000369	CcSEcCtD
Pergolide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000369	CcSEcCtD
Pergolide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000132	0.000369	CcSEcCtD
Pergolide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000368	CcSEcCtD
Pergolide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000131	0.000368	CcSEcCtD
Pergolide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000367	CcSEcCtD
Pergolide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000367	CcSEcCtD
Pergolide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000367	CcSEcCtD
Pergolide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000366	CcSEcCtD
Pergolide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000366	CcSEcCtD
Pergolide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000365	CcSEcCtD
Pergolide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000365	CcSEcCtD
Pergolide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000363	CcSEcCtD
Pergolide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000363	CcSEcCtD
Pergolide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000363	CcSEcCtD
Pergolide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00013	0.000363	CcSEcCtD
Pergolide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00013	0.000363	CcSEcCtD
Pergolide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000362	CcSEcCtD
Pergolide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000362	CcSEcCtD
Pergolide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000362	CcSEcCtD
Pergolide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000361	CcSEcCtD
Pergolide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000129	0.000361	CcSEcCtD
Pergolide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00036	CcSEcCtD
Pergolide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00036	CcSEcCtD
Pergolide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00036	CcSEcCtD
Pergolide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000359	CcSEcCtD
Pergolide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000359	CcSEcCtD
Pergolide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000358	CcSEcCtD
Pergolide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000358	CcSEcCtD
Pergolide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000356	CcSEcCtD
Pergolide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000356	CcSEcCtD
Pergolide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000355	CcSEcCtD
Pergolide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000355	CcSEcCtD
Pergolide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000355	CcSEcCtD
Pergolide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000354	CcSEcCtD
Pergolide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000353	CcSEcCtD
Pergolide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000353	CcSEcCtD
Pergolide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000352	CcSEcCtD
Pergolide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.000352	CcSEcCtD
Pergolide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000125	0.000351	CcSEcCtD
Pergolide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000351	CcSEcCtD
Pergolide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000125	0.000351	CcSEcCtD
Pergolide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000125	0.00035	CcSEcCtD
Pergolide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.00035	CcSEcCtD
Pergolide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00035	CcSEcCtD
Pergolide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000125	0.000349	CcSEcCtD
Pergolide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000124	0.000348	CcSEcCtD
Pergolide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000348	CcSEcCtD
Pergolide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000348	CcSEcCtD
Pergolide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000347	CcSEcCtD
Pergolide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000347	CcSEcCtD
Pergolide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000347	CcSEcCtD
Pergolide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000347	CcSEcCtD
Pergolide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000123	0.000345	CcSEcCtD
Pergolide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000123	0.000345	CcSEcCtD
Pergolide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000345	CcSEcCtD
Pergolide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000345	CcSEcCtD
Pergolide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000123	0.000343	CcSEcCtD
Pergolide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000343	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000342	CcSEcCtD
Pergolide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000342	CcSEcCtD
Pergolide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000342	CcSEcCtD
Pergolide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00034	CcSEcCtD
Pergolide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000339	CcSEcCtD
Pergolide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000338	CcSEcCtD
Pergolide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000338	CcSEcCtD
Pergolide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000337	CcSEcCtD
Pergolide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000336	CcSEcCtD
Pergolide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000336	CcSEcCtD
Pergolide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000335	CcSEcCtD
Pergolide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000335	CcSEcCtD
Pergolide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000334	CcSEcCtD
Pergolide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000333	CcSEcCtD
Pergolide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000332	CcSEcCtD
Pergolide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000331	CcSEcCtD
Pergolide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000331	CcSEcCtD
Pergolide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000331	CcSEcCtD
Pergolide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000118	0.00033	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000329	CcSEcCtD
Pergolide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000329	CcSEcCtD
Pergolide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000327	CcSEcCtD
Pergolide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000327	CcSEcCtD
Pergolide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000325	CcSEcCtD
Pergolide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000325	CcSEcCtD
Pergolide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000322	CcSEcCtD
Pergolide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000322	CcSEcCtD
Pergolide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000322	CcSEcCtD
Pergolide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000321	CcSEcCtD
Pergolide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000321	CcSEcCtD
Pergolide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000321	CcSEcCtD
Pergolide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000321	CcSEcCtD
Pergolide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000321	CcSEcCtD
Pergolide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.00032	CcSEcCtD
Pergolide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000318	CcSEcCtD
Pergolide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000318	CcSEcCtD
Pergolide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000314	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000314	CcSEcCtD
Pergolide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000312	CcSEcCtD
Pergolide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00031	CcSEcCtD
Pergolide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00031	CcSEcCtD
Pergolide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000309	CcSEcCtD
Pergolide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000309	CcSEcCtD
Pergolide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000308	CcSEcCtD
Pergolide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000307	CcSEcCtD
Pergolide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000307	CcSEcCtD
Pergolide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000307	CcSEcCtD
Pergolide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000307	CcSEcCtD
Pergolide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000305	CcSEcCtD
Pergolide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000305	CcSEcCtD
Pergolide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000304	CcSEcCtD
Pergolide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000304	CcSEcCtD
Pergolide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000108	0.000303	CcSEcCtD
Pergolide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.0003	CcSEcCtD
Pergolide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.0003	CcSEcCtD
Pergolide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000298	CcSEcCtD
Pergolide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000297	CcSEcCtD
Pergolide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000297	CcSEcCtD
Pergolide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000297	CcSEcCtD
Pergolide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000296	CcSEcCtD
Pergolide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000295	CcSEcCtD
Pergolide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000295	CcSEcCtD
Pergolide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000291	CcSEcCtD
Pergolide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000291	CcSEcCtD
Pergolide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000287	CcSEcCtD
Pergolide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000287	CcSEcCtD
Pergolide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000286	CcSEcCtD
Pergolide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000286	CcSEcCtD
Pergolide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000286	CcSEcCtD
Pergolide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000284	CcSEcCtD
Pergolide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000283	CcSEcCtD
Pergolide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000283	CcSEcCtD
Pergolide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000282	CcSEcCtD
Pergolide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000282	CcSEcCtD
Pergolide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000281	CcSEcCtD
Pergolide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.93e-05	0.000278	CcSEcCtD
Pergolide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.74e-05	0.000273	CcSEcCtD
Pergolide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.74e-05	0.000273	CcSEcCtD
Pergolide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.64e-05	0.00027	CcSEcCtD
Pergolide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.00027	CcSEcCtD
Pergolide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.59e-05	0.000269	CcSEcCtD
Pergolide—Rash—Efavirenz—acquired immunodeficiency syndrome	9.56e-05	0.000268	CcSEcCtD
Pergolide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.55e-05	0.000267	CcSEcCtD
Pergolide—Nausea—Indinavir—acquired immunodeficiency syndrome	9.53e-05	0.000267	CcSEcCtD
Pergolide—Headache—Efavirenz—acquired immunodeficiency syndrome	9.5e-05	0.000266	CcSEcCtD
Pergolide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000266	CcSEcCtD
Pergolide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000259	CcSEcCtD
Pergolide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.23e-05	0.000258	CcSEcCtD
Pergolide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.18e-05	0.000257	CcSEcCtD
Pergolide—Rash—Delavirdine—acquired immunodeficiency syndrome	9.15e-05	0.000256	CcSEcCtD
Pergolide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.14e-05	0.000256	CcSEcCtD
Pergolide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.14e-05	0.000256	CcSEcCtD
Pergolide—Headache—Delavirdine—acquired immunodeficiency syndrome	9.09e-05	0.000255	CcSEcCtD
Pergolide—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.000252	CcSEcCtD
Pergolide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.87e-05	0.000248	CcSEcCtD
Pergolide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000247	CcSEcCtD
Pergolide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000247	CcSEcCtD
Pergolide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.000244	CcSEcCtD
Pergolide—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000241	CcSEcCtD
Pergolide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.54e-05	0.000239	CcSEcCtD
Pergolide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.53e-05	0.000239	CcSEcCtD
Pergolide—Rash—Ritonavir—acquired immunodeficiency syndrome	8.46e-05	0.000237	CcSEcCtD
Pergolide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.45e-05	0.000237	CcSEcCtD
Pergolide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.000236	CcSEcCtD
Pergolide—Headache—Ritonavir—acquired immunodeficiency syndrome	8.41e-05	0.000235	CcSEcCtD
Pergolide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.21e-05	0.00023	CcSEcCtD
Pergolide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.15e-05	0.000228	CcSEcCtD
Pergolide—Rash—Saquinavir—acquired immunodeficiency syndrome	8.14e-05	0.000228	CcSEcCtD
Pergolide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.000228	CcSEcCtD
Pergolide—Headache—Saquinavir—acquired immunodeficiency syndrome	8.09e-05	0.000227	CcSEcCtD
Pergolide—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.97e-05	0.000223	CcSEcCtD
Pergolide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.83e-05	0.000219	CcSEcCtD
Pergolide—Rash—Lamivudine—acquired immunodeficiency syndrome	7.77e-05	0.000218	CcSEcCtD
Pergolide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000217	CcSEcCtD
Pergolide—Headache—Lamivudine—acquired immunodeficiency syndrome	7.72e-05	0.000216	CcSEcCtD
Pergolide—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.67e-05	0.000215	CcSEcCtD
Pergolide—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000205	CcSEcCtD
Pergolide—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.03e-05	0.000366	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.03e-05	0.000366	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.03e-05	0.000366	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.03e-05	0.000365	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.03e-05	0.000365	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.03e-05	0.000365	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.01e-05	0.000364	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.99e-05	0.000361	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.99e-05	0.000361	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.99e-05	0.000361	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.99e-05	0.00036	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.99e-05	0.00036	CbGpPWpGaD
Pergolide—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.95e-05	0.000356	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.94e-05	0.000355	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.94e-05	0.000355	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.94e-05	0.000355	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.93e-05	0.000354	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.92e-05	0.000352	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.000351	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.89e-05	0.000349	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.89e-05	0.000348	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.87e-05	0.000347	CbGpPWpGaD
Pergolide—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.87e-05	0.000347	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.84e-05	0.000342	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.84e-05	0.000342	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.82e-05	0.00034	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.82e-05	0.00034	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.81e-05	0.000339	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.81e-05	0.000339	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.8e-05	0.000337	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.79e-05	0.000337	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.000337	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.000337	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.000335	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.000335	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.77e-05	0.000335	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.000334	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.76e-05	0.000332	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000332	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000332	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.74e-05	0.00033	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.73e-05	0.00033	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.73e-05	0.00033	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.69e-05	0.000325	CbGpPWpGaD
Pergolide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.68e-05	0.000323	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.68e-05	0.000323	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000322	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.66e-05	0.000321	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.65e-05	0.000319	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.65e-05	0.000319	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.64e-05	0.000319	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.63e-05	0.000317	CbGpPWpGaD
Pergolide—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.62e-05	0.000316	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.000315	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.000315	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.000315	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.000315	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.59e-05	0.000313	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.58e-05	0.000311	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.57e-05	0.000311	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.57e-05	0.00031	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.000308	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.55e-05	0.000308	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.55e-05	0.000308	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.55e-05	0.000308	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000306	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.000306	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.53e-05	0.000306	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.000304	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.51e-05	0.000303	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.51e-05	0.000303	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000302	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000301	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.48e-05	0.000299	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.46e-05	0.000297	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.44e-05	0.000295	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.000292	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.41e-05	0.000291	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.36e-05	0.000285	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.36e-05	0.000285	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.35e-05	0.000284	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.34e-05	0.000283	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.32e-05	0.00028	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.00028	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.31e-05	0.000279	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.000278	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.31e-05	0.000278	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.000276	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.000276	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.28e-05	0.000275	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.28e-05	0.000275	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.28e-05	0.000275	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.27e-05	0.000274	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.27e-05	0.000274	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.27e-05	0.000273	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000273	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.27e-05	0.000273	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.25e-05	0.000272	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.24e-05	0.00027	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.24e-05	0.00027	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.00027	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.21e-05	0.000266	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000266	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.2e-05	0.000266	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000266	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.17e-05	0.000262	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.17e-05	0.000262	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.000262	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.000262	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.000258	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.13e-05	0.000257	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.11e-05	0.000254	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.000254	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.09e-05	0.000252	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.09e-05	0.000252	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	2.09e-05	0.000252	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.08e-05	0.00025	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.07e-05	0.00025	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.05e-05	0.000247	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.000247	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.05e-05	0.000247	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.000243	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.000243	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2e-05	0.000242	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2e-05	0.000241	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2e-05	0.000241	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.00024	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.00024	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.000239	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.97e-05	0.000238	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.97e-05	0.000237	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.97e-05	0.000237	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.000236	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.000236	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.95e-05	0.000236	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000233	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000233	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.93e-05	0.000232	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.93e-05	0.000232	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.000232	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.9e-05	0.00023	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.88e-05	0.000227	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.82e-05	0.000219	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000216	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000216	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000216	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.000216	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.000216	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000214	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.000213	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.75e-05	0.000211	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.75e-05	0.000211	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.74e-05	0.00021	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.000209	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.72e-05	0.000208	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000206	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.7e-05	0.000205	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000203	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.68e-05	0.000202	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000202	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000199	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000199	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.63e-05	0.000196	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000196	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000195	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.6e-05	0.000193	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000191	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.58e-05	0.00019	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000189	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000188	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.55e-05	0.000187	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000184	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.000183	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000183	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000182	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000181	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000181	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000179	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000178	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000178	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000178	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000177	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000175	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000175	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.44e-05	0.000174	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.42e-05	0.000172	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000165	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000164	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000163	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000162	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000162	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000159	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000159	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000159	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000156	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.29e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000148	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000146	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.2e-05	0.000145	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000145	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000143	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.18e-05	0.000142	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000141	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.16e-05	0.00014	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000134	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.11e-05	0.000133	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000127	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.05e-05	0.000126	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000126	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000125	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000125	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000124	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000124	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.34e-06	0.000113	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.3e-06	0.000112	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.28e-06	0.000112	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.02e-06	0.000109	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.97e-06	0.000108	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.97e-06	0.000108	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.93e-06	0.000108	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.73e-06	0.000105	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.68e-06	0.000105	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.59e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.55e-06	0.000103	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.92e-06	9.55e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.88e-06	9.5e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.79e-06	9.4e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.75e-06	9.35e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.63e-06	9.2e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.59e-06	9.16e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.11e-06	8.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.09e-06	8.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.05e-06	8.51e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.96e-06	8.39e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.85e-06	8.26e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.81e-06	8.22e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.54e-06	7.88e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.16e-06	7.44e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.08e-06	7.34e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.08e-06	7.34e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.49e-06	6.62e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.3e-06	6.39e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.27e-06	6.36e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.13e-06	6.19e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.05e-06	6.09e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.65e-06	5.61e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.58e-06	5.52e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.48e-06	5.41e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.45e-06	5.37e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.17e-06	5.03e-05	CbGpPWpGaD
